Sponsor or institution

Clinical trials and research at Innovent Biologics Technology Limited (Shanghai R&D Center)

• 2Clinical trials
• 1Country

All recruiting trials (2)

• IBI3026 for locally advanced, unresectable, or metastatic solid tumors

  This trial tests IBI3026 in adults with solid tumors that are locally advanced, cannot be removed, or have spread to find safe doses and see if it can shrink tumors or slow their growth.

  Recruiting Early Phase 1 Innovent Biologics Technology Limited (Shanghai R&D Center) · Chengdu, Sichuan · NCT07327632

• IBI302 treatment for neovascular age-related macular degeneration

  This trial will try intravitreal 8 mg IBI302 injections to see if they help people aged 50 and older with active neovascular (wet) AMD.

  Recruiting Phase 2 Innovent Biologics Technology Limited (Shanghai R&D Center) · Shanghai, Shanghai Municipality · NCT07275840

Quick answers

How many clinical trials run by Innovent Biologics Technology Limited (Shanghai R&D Center) are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →